# Effect of Apiban Therapy on AVF Maturation in ESRD Patients

> **NCT07559942** · NA · RECRUITING · sponsor: **Combined military hospital lahore** · enrollment: 190 (estimated)

## Conditions studied

- Endstage Renal Disease
- Direct Oral Anticoagulants (DOACs)
- Arteriovenous Fistula
- Arteriovenous Fistula Occlusion

## Interventions

- **DRUG:** Apixaban

## Key facts

- **NCT ID:** NCT07559942
- **Lead sponsor:** Combined military hospital lahore
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-01
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-08-31
- **Target enrollment:** 190 (ESTIMATED)
- **Last updated:** 2026-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07559942

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07559942, "Effect of Apiban Therapy on AVF Maturation in ESRD Patients". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT07559942. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*